<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03527485</url>
  </required_header>
  <id_info>
    <org_study_id>2000021843</org_study_id>
    <nct_id>NCT03527485</nct_id>
  </id_info>
  <brief_title>Imaging Synaptic Density in Cocaine and Opiate Addiction In Vivo Using 11UCB-J PET</brief_title>
  <official_title>Imaging Synaptic Density in Cocaine and Opiate Addiction In Vivo Using 11UCB-J PET</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yale University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to measure synaptic density in the brains (including in ventral striatum [VS]&#xD;
      and medial prefrontal cortex [mPFC]) of abstinent subjects with Cocaine Use Disorder (CUD) or&#xD;
      Opiate Use Disorder (OUD) as compared to healthy control (HC) subjects using 11C-UCB-J PET.&#xD;
      Subjects will undergo a single 11C-UCB-J (also known as 11C-APP311) PET scan.&#xD;
&#xD;
      This would be the very first to image synaptic density in human cocaine and opiate users,&#xD;
      thereby testing whether altered synaptic density in the rodent brain is recapitulated in CUD&#xD;
      and OUD humans. If confirmed, the current study would provide compelling&#xD;
      clinical-translational support for an important pathophysiological mechanism of addiction -&#xD;
      aberrant structural synaptic plasticity. As such, the current study has considerable&#xD;
      potential for advancing the neurobiological understanding of human cocaine and opiate&#xD;
      addiction.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Anticipated">January 2024</completion_date>
  <primary_completion_date type="Anticipated">January 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>11C-UCB-J PET synaptic density</measure>
    <time_frame>90 minute scan</time_frame>
    <description>PET scan</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Opiate Dependence</condition>
  <condition>Cocaine Dependence</condition>
  <arm_group>
    <arm_group_label>Opiate Use Disorder (OUD)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>30 subjects meeting opiate dependence criteria will receive 11UCB-J PET Scan.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cocaine Use Disorder (CUD)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>30 subjects meeting cocaine dependence criteria 11UCB-J PET Scan.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Controls (HC)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>30 healthy controls; no substance dependence or mental health issues 11UCB-J PET Scan.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>11UCB-J PET Scan</intervention_name>
    <description>11UCB-J PET Scan</description>
    <arm_group_label>Cocaine Use Disorder (CUD)</arm_group_label>
    <arm_group_label>Healthy Controls (HC)</arm_group_label>
    <arm_group_label>Opiate Use Disorder (OUD)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 21-55 years;&#xD;
&#xD;
          -  Voluntary, written, informed consent;&#xD;
&#xD;
          -  Physically healthy by medical history, physical, neurological, ECG and laboratory&#xD;
             examinations;&#xD;
&#xD;
          -  DSM-5 criteria for Cocaine Use Disorder or Opiate Use Disorder;&#xD;
&#xD;
          -  Documented evidence (by urine toxicology) of 2 weeks abstinence from cocaine and 4&#xD;
             weeks abstinence from opiates;&#xD;
&#xD;
          -  For females, a negative serum pregnancy (HCG) test;&#xD;
&#xD;
          -  Full scale and verbal IQs &gt; 80 (Wechsler Adult Intelligence Scale, Fourth Edition&#xD;
             (WAIS-IV)).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  A history of other substance dependence (e.g., alcohol, sedative hypnotics), except&#xD;
             for nicotine;&#xD;
&#xD;
          -  A primary DSM-5 Axis I major psychiatric disorder (e.g., schizophrenia, bipolar&#xD;
             disorder, major depression, etc.) as determined by the Structured Clinical Interview&#xD;
             for DSM-5 (SCID-5);&#xD;
&#xD;
          -  A history of significant and uncontrolled medical (e.g., cardiovascular,&#xD;
             diabetic/metabolic) or neurological (e.g., cerebrovascular, seizures, traumatic brain&#xD;
             injury) illness;&#xD;
&#xD;
          -  A history of seizures;&#xD;
&#xD;
          -  Current use of psychotropic and/or potentially psychoactive prescription medications;&#xD;
&#xD;
          -  Medical contraindications to participation in a magnetic resonance (MR) imaging&#xD;
             procedure (e.g., ferromagnetic implants/foreign bodies, claustrophobia, cardiac&#xD;
             pacemaker, prosthetic valve, otologic implant, etc.) as recorded on the MR safety&#xD;
             sheet;&#xD;
&#xD;
          -  For females, physical or laboratory (HCG) evidence of pregnancy;&#xD;
&#xD;
          -  PTT and PT/INR lab results not appropriate for arterial line placement;&#xD;
&#xD;
          -  Taking anticoagulants;&#xD;
&#xD;
          -  Being prescribed methadone/buprenorphine upon screening.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ben Kazer</last_name>
    <phone>(203) 974-7253</phone>
    <email>benjamin.kazer@yale.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>CT Mental Health Center</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06519</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Costeines, MSW</last_name>
      <phone>203-974-7559</phone>
      <email>jessica.costeines@yale.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>April 19, 2018</study_first_submitted>
  <study_first_submitted_qc>May 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 17, 2018</study_first_posted>
  <last_update_submitted>February 5, 2021</last_update_submitted>
  <last_update_submitted_qc>February 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cocaine-Related Disorders</mesh_term>
    <mesh_term>Opioid-Related Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

